department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Nicorette · pharmadog

pharmadog
drugs
Nicorette

drug

patient view →

nicotine

Marketedupdated 2mo ago

by NAL Pharmaceuticals Ltd

Approved

community read0 votes

all catalysts(1)

phase 2 3 initiation · 1

phase 2 3 initiation

Pacific Dental College and Hospital — nicotine (Phase II/III Trial Initiation)

News(0)

no news has mentioned this drug yet

brand

Nicorette

generic

nicotine [USP]

indication

Smoking Cessation

phase

marketed

Patent cliff

source: FDA Orange Book

first barrier falls

Apr 30, 2028

~1.8 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (6)

Jun 14, 2029formulationUS 85011642.9y
Jun 14, 2029formulationUS 85011642.9y
Apr 30, 2029formulationUS 89407722.8y
Apr 30, 2029formulationUS 89407722.8y
Apr 30, 2028formulationUS 83236831.8y
Apr 30, 2028patentUS 83236831.8y

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 5

drugnicotine ER11 co-mentions · 11 sources
tagApproval8 co-mentions · 4 sources
drugnicotine polacrilex4 co-mentions · 4 sources
companyWake Forest University1 co-mentions · 1 sources
companyPacific Dental College and Hospital1 co-mentions · 1 sources

Trials studying nicotine

EP1Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Canceractive not recruitingn=630
N/AExploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Tablet (NICOTINE TABLET) on Attentionactive not recruitingn=40
phase4Reward Sensitivity and Pharmacotherapy for Smoking Cessationactive not recruitingn=204
phase3Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responderscompletedn=150
phase4C-Raven, a Virtual Tobacco Cessation Intervention in the Communitycompletedn=10
N/AA Bioavailability Study of Nicotine Delivered by an Electronic Vapour Productcompletedn=12
N/ACSD231005 Nicotine Pouch Biomarkers of Exposurecompletedn=200
phase3Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRTterminatedn=4

more trials →